Actively Recruiting
Blood Sample Collection for Adults with Primary or Metastatic Brain Tumors to Study Biomarkers Related to Radiation Therapy
Led by Duke University · Updated on 2025-11-19
300
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are creating a blood sample repository from adults diagnosed with primary or metastatic brain tumors treated at the Duke Cancer Center Radiation Oncology Department. This observational study aims to explore how circulating biomarkers relate to outcomes following radiation therapy in these patients. Participants provide blood samples that will be studied to understand the association between circulating immune cells and treatment effects. The research focuses on collecting samples at specific times, including six weeks after radiation therapy, to measure immune cell levels. During the study, participants undergo blood draws for sample collection, and researchers monitor the number of circulating immune cells in the blood six weeks post-treatment. The study involves no active intervention, and participation duration varies depending on treatment schedules and sample collection timing. The main outcome is the number of circulating immune cells after radiation therapy.
CONDITIONS
Brief Title
Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
Research Team
K
Kaitlin Bailey, RN OCN
L
Linda Kaltenbach, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
